Effect of dexmedetomidine on plasma brain-derived neurotrophic factor: A double-blind, randomized and placebo-controlled study

Upsala Journal of Medical Sciences

Volumn 118, Issue 4, 2013, Pages 235-239

  Yang, Lin ^a   Xu, Jun Mei ^a   Jiang, Xinghua ^a   Ruan, Wei ^a   Cui, Yulong ^a   He, Liang ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Anesthetic drugs; Brain derived neurotrophic factor (BDNF); Dexmedetomidine

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR, HUMAN; BRAIN-DERIVED NEUROTROPHIC FACTOR, HUMAN; DEXMEDETOMIDINE; HYPNOTIC SEDATIVE AGENT;

ADULT; ARTICLE; BLOOD; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; GENERAL ANESTHESIA; HEART RATE; HUMAN; INTERVERTEBRAL DISK DEGENERATION; INTERVERTEBRAL DISKECTOMY; LUMBAR VERTEBRA; MALE; METHODOLOGY; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; TIME;

ADULT; ANESTHESIA, GENERAL; BRAIN-DERIVED NEUROTROPHIC FACTOR; DEXMEDETOMIDINE; DISKECTOMY; DOUBLE-BLIND METHOD; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEART RATE; HUMANS; HYPNOTICS AND SEDATIVES; INTERVERTEBRAL DISC DEGENERATION; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; TIME FACTORS;

EID: 84885466811     PISSN: 03009734     EISSN: None     Source Type: Journal    
DOI: 10.3109/03009734.2013.808295     Document Type: Article

References (26)

1. Sossin WS, Barker PA. Something old, something new: BDNF-induced neuron survival requires TRPC channel function. Nat Neurosci. 2007;10:537-8.
2. Chao MV, Rajagopal R, Lee FS. Neurotrophin signalling in health and disease. Clin Sci. 2006;110:167-73.
3. Nagahara AH, Merrill DA, Coppola G, Tsukada S, Schroeder BE, Shaked GM, et al. Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease. Nat Med. 2009;15:331-7.
4. Pan W, Banks WA, Fasold MB, Bluth J, Kastin AJ. Transport of brain-derived neurotrophic factor across the blood-brain barrier. Neuropharmacology. 1998;12:1553-61.
5. Karege F, Schwald M, Cisse M. Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets. Neurosci Lett. 2002;3:261-4.
6. Balkowiec A, Katz DM. Cellular mechanisms regulating activity-dependent release of native brain-derived neuro-trophic factor from hippocampal neurons. J Neurosci. 2002; 23:10399-407.
7. Goggi J, Pullar IA, Carney SL, Bradford HF. The control of [125I] BDNF release from striatal rat brain slices. Brain Res. 2003;967:201-9.
8. Vutskits L, Lysakowski C, Czarnetzki C, Jenny B, Copin JC, Tramèr MR. Plasma Concentrations of brain-derived neuro-trophic factor in patients undergoing minor surgery: a randomized controlled trial. Neurochem Res. 2008;33: 1325-31.
9. Bhana N, Goa KL, McClellan KJ. Dexmedetomidine. Drugs. 2000;59:263-8.
10. Janke EL, Samra S. Dexmedetomidine and neuroprotection. Seminars in Anesthesia, Perioperative Medicine and Pain. 2006;25:71-6.
11. Yan M, Dai H, Ding T, Dai A, Zhang F, Yu L, et al. Effects of dexmedetomidine on the release of glial cell line-derived neurotrophic factor from rat astrocyte cells. Neurochem Int. 2011;58:549-57.
12. Eser O, Fidan H, Sahin O, Cosar M, Yaman M, Mollaoglu H, et al. The influence of dexmedetomidine on ischemic rat hippocampus. Brain Res. 2008;1218:250-6.
13. Dahmani S, Rouelle D, Gressens P, Mantz J. Effect of dexmedetomidine on brain derived neurotrophic factor expression in rat hippocampal slices [abstract]. Anesthesiol-ogy. 2006;105:681.
14. Lommatzsch M, Zingler D, Schuhbaeck K, Schloetcke K, Zingler C, Schuff-Werner P, et al. The impact of age, weight and gender on BDNF levels in human platelets and plasma. Neurobiol Aging. 2005;26:115-23.
15. Radka SF, Holst PA, Fritsche M, Altar CA. Presence of brain-derived neurotrophic factor in brain and human and rat but not mouse serum detected by a sensitive and specific immunoassay. Brain Res. 1996;1:122-301.
16. Lommatzsch M, Braun A, Mannsfeldt A, Botchkarev VA, Botchkareva NV, Paus R, et al. Abundant production of brain-derived neurotrophic factor by adult visceral epithelia. Implications for paracrine and target-derived Neuro-trophic functions. Am J Pathol. 1999;155:1183-93.
17. Nakahashi T, Fujimura H, Altar CA, Li J, Kambayashi J, Tandon NN, et al. Vascular endothelial cells synthesize and secrete brain-derived neurotrophic factor. FEBS Lett. 2000; 470:113-17.
18. Hohlfeld R, Kerschensteiner M, Meinl E. Dual role of inflammation in CNS disease. Neurology. 2007;68:58-63.
19. Martinowich K, Manji H, Lu B. New insights into BDNF function in depression and anxiety. Nat Neurosci. 2007;10: 1089-93.
20. Lee BH, Kim H, Park SH, Kim YK. Decreased plasma BDNF level in depressive patients. J Affect Disord. 2007;101:239-44.
21. Winter B, Breitenstein C, Mooren FC, Voelker K, Fobker M, Lechtermann A, et al. High impact running improves learning. Neurobiol Learn Mem. 2007;87:597-609.
22. Lu LX, Yon JH, Carter LB, Jevtovic-Todorovic V. General anesthesia activates BDNF-dependent neuroapoptosis in the developing rat brain. Apoptosis. 2006;11:1603-15.
23. Perouansky M, Hemmings HC Jr. Neurotoxicity of general anesthetics: cause for concern? Anesthesiology. 2009;111: 1365-71.
24. Sanders RD, Xu J, Shu Y, Januszewski A, Halder S, Fidalgo A, et al. Dexmedetomidine attenuates isoflurane-induced neurocognitive impairment in neonatal rats. Anes-thesiology. 2009;110:1077-85.
25. Scheinin B, Lindgren L, Randell T, Scheinin H, Scheinin M. Dexmedetomidine attenuates sympathoadrenal responses to tracheal intubation and reduces the need for thiopentone and peri-operative fentanyl. Br J Anaesth. 1992;68:126-31.
26. Maldonado JR, Wysong A, van der Starre PJ, Block T, Miller C, Reitz BA. Dexmedetomidine and the reduction of postoperative delirium after cardiac surgery. Psychosomatics. 2009;50:206-17.